PROCEPT BioRobotics Files 8-K on Financial Results
Ticker: PRCT · Form: 8-K · Filed: Feb 27, 2024 · CIK: 1588978
Sentiment: neutral
Topics: financial-results, 8-K filing, disclosure
Related Tickers: PRCT
TL;DR
**PROCEPT BioRobotics just filed an 8-K disclosing its latest financial results and condition.**
AI Summary
PROCEPT BioRobotics Corporation filed an 8-K on February 27, 2024, to report its results of operations and financial condition, along with related financial statements and exhibits. This filing, under SEC File Number 001-40797, indicates the company is providing an update on its financial performance and status.
Why It Matters
This routine 8-K filing provides investors with the latest financial performance and condition of PROCEPT BioRobotics, offering transparency and essential data for informed investment decisions.
Risk Assessment
Risk Level: low — This 8-K is a standard disclosure of financial results and condition, not indicating any immediate high-risk events from the provided text.
Key Numbers
- February 27, 2024 — Date of Report (earliest event reported)
- 001-40797 — SEC File Number (registrant's commission file number)
Key Players & Entities
- PROCEPT BioRobotics Corporation (company) — registrant
- United States Securities and Exchange Commission (company) — regulator
- Delaware (location) — state of incorporation
- San Jose, California (location) — business address
FAQ
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is PROCEPT BIOROBOTICS CORPORATION.
What was the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported was February 27, 2024.
What specific items of information were reported in this 8-K?
The 8-K reported "Results of Operations and Financial Condition" and "Financial Statements and Exhibits."
What is the business address of PROCEPT BioRobotics Corporation?
The business address is 150 Baytech Drive, San Jose, California 95134.
What is the Commission File Number for PROCEPT BioRobotics Corporation?
The Commission File Number is 001-40797.
Filing Stats: 510 words · 2 min read · ~2 pages · Grade level 13.2 · Accepted 2024-02-27 16:07:10
Key Financial Figures
- $0.00001 — ge on which registered Common Stock, $0.00001 par value per share PRCT The Nasdaq Glo
Filing Documents
- prct-20240227.htm (8-K) — 28KB
- prct_q42023earningsrelease.htm (EX-9.01) — 157KB
- image_0a.jpg (GRAPHIC) — 15KB
- 0001588978-24-000004.txt ( ) — 342KB
- prct-20240227.xsd (EX-101.SCH) — 2KB
- prct-20240227_lab.xml (EX-101.LAB) — 23KB
- prct-20240227_pre.xml (EX-101.PRE) — 12KB
- prct-20240227_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition On February 27, 2024 , PROCEPT BioRobotics Corporation (the "Company") issued a press release announcing its financial results for the quarter ended December 31, 2023. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release of PROCEPT BioRobotics Corporation, dated February 27, 2024 104 Cover Page Interactive Data File, formatted in Inline XBRL.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PROCEPT BIOROBOTICS CORPORATION Date: February 27, 2024 By: /s/ Alaleh Nouri Alaleh Nouri Chief Legal Officer and Secretary